Suppr超能文献

相似文献

1
YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12165-70. doi: 10.1073/pnas.0402283101. Epub 2004 Aug 4.
2
MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
EMBO J. 2005 Sep 21;24(18):3279-90. doi: 10.1038/sj.emboj.7600791. Epub 2005 Aug 18.
3
Yin Yang 1 is a negative regulator of p53.
Cell. 2004 Jun 25;117(7):859-72. doi: 10.1016/j.cell.2004.06.004.
4
Inhibition of p53 degradation by Mdm2 acetylation.
FEBS Lett. 2004 Mar 12;561(1-3):195-201. doi: 10.1016/S0014-5793(04)00168-1.
5
YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Biochem Biophys Res Commun. 2004 May 28;318(2):615-24. doi: 10.1016/j.bbrc.2004.04.065.
6
MDMX inhibits the p300/CBP-mediated acetylation of p53.
DNA Cell Biol. 2002 Jul;21(7):519-25. doi: 10.1089/104454902320219077.
7
Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination.
EMBO J. 2005 Jul 6;24(13):2425-35. doi: 10.1038/sj.emboj.7600712. Epub 2005 Jun 2.
8
SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
J Mol Biol. 2009 May 15;388(4):691-702. doi: 10.1016/j.jmb.2009.03.033. Epub 2009 Mar 19.
9
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
J Cell Sci. 2007 Jul 1;120(Pt 13):2259-71. doi: 10.1242/jcs.03468.

引用本文的文献

2
Yin Yang 1: Function, Mechanisms, and Glia.
Neurochem Res. 2025 Feb 4;50(2):96. doi: 10.1007/s11064-025-04345-7.
3
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1.
Cancers (Basel). 2024 Mar 21;16(6):1237. doi: 10.3390/cancers16061237.
4
Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy.
Cancers (Basel). 2024 Jan 23;16(3):491. doi: 10.3390/cancers16030491.
5
Multigeneration Exposure to Carbendazim: Gene Transcription Responses.
Toxics. 2023 Nov 10;11(11):918. doi: 10.3390/toxics11110918.
6
A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.
Adv Sci (Weinh). 2023 Nov;10(33):e2305096. doi: 10.1002/advs.202305096. Epub 2023 Oct 16.
7
Zinc Ions Modulate YY1 Activity: Relevance in Carcinogenesis.
Cancers (Basel). 2023 Aug 30;15(17):4338. doi: 10.3390/cancers15174338.
8
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.
Cancers (Basel). 2023 Jul 5;15(13):3506. doi: 10.3390/cancers15133506.
9
Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer.
Cell Oncol (Dordr). 2023 Oct;46(5):1457-1472. doi: 10.1007/s13402-023-00823-8. Epub 2023 Jun 16.

本文引用的文献

1
Yin Yang 1 is a negative regulator of p53.
Cell. 2004 Jun 25;117(7):859-72. doi: 10.1016/j.cell.2004.06.004.
2
HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.
EMBO J. 2004 Jun 2;23(11):2269-80. doi: 10.1038/sj.emboj.7600239. Epub 2004 May 13.
3
p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels.
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7386-91. doi: 10.1073/pnas.0401002101. Epub 2004 Apr 27.
4
YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Biochem Biophys Res Commun. 2004 May 28;318(2):615-24. doi: 10.1016/j.bbrc.2004.04.065.
5
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2259-64. doi: 10.1073/pnas.0308762101.
7
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
Science. 2003 Dec 12;302(5652):1972-5. doi: 10.1126/science.1091362.
10
Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
Science. 2003 Apr 11;300(5617):342-4. doi: 10.1126/science.1080386.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验